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Background:  The highly developed endoplasmic reticulum (ER) structure in pancreatic beta cells is heavily involved in insulin 
biosynthesis. Thus, any perturbation in ER function inevitably impacts insulin biosynthesis. Recent studies showed that the ex-
pression of tribbles-related protein 3 (TRB3), a mammalian homolog of Drosophilia tribbles, in various cell types is induced by 
ER stress. Here, we examined whether ER stress induces TRB3 expression in INS-1 cells and found that TRB3 mediates ER stress-
induced suppression of insulin gene expression. 
Methods:  The effects of tunicamycin and thapsigargin on insulin and TRB3 expression in INS-1 cells were measured by North-
ern and Western blot analysis, respectively. The effects of adenovirus-mediated overexpression of TRB3 on insulin, PDX-1 and 
MafA gene expression in INS-1 cells were measured by Northern blot analysis. The effect of TRB3 on insulin promoter was mea-
sured by transient transfection study with constructs of human insulin promoter. 
Results:  The treatment of INS-1 cells with tunicamycin and thapsigargin decreased insulin mRNA expression, but increased 
TRB3 protein expression. Adenovirus-mediated overexpression of TRB3 decreased insulin gene expression in a dose-dependent 
manner. A transient transfection study showed that TRB3 inhibited insulin promoter activity, suggesting that TRB3 inhibited in-
sulin gene expression at transcriptional level. Adenovirus-mediated overexpression of TRB3 also decreased PDX-1 mRNA ex-
pression, but did not influence MafA mRNA expression. 
Conclusions:  This study showed that ER stress induced TRB3 expression, but decreased both insulin and PDX-1 gene expression 
in INS-1 cells. Our data suggest that TRB3 plays an important role in ER stress-induced beta cell dysfunction. 
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INTRODUCTION
The endoplasmic reticulum (ER), a membrane component that 
is located near the nucleus, is an organelle where amino acids 
synthesized by mRNA become mature proteins after going 
through folding, assembly, glycosylation, disulfide bonding, 
and post-translational modifications [1]. ER stress is induced 
by a large influx of immature proteins that the ER cannot man-
age or the depletion of calcium by physiological or pathologi-
cal environment [1-3]. The ER is well developed in endocrine 
cells such as pancreatic beta cells in which proteins are synthe-
size and secreted. Active insulin is made in the ER from prep-
roinsulin, which is converted to proinsulin by post-translation-
al modification and disulfide bond formation, and then remov-
al of C-peptide [4,5]. Because the ER of pancreatic beta cells 
plays an important role in synthesizing and secreting active in-
sulin, any ER stress by pathological conditions can impair the 
biosynthesis of insulin [6]. 
  When ER stress occurs, cellular defense mechanisms related 
to ER stress response are activated for the survival of the cells 
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[1-3]. The ER stress response is made up of: 1) activation of pro-
tein kinase RNA (PKR)-like ER kinase (PERK) and reduction 
of mRNA to protein translation by phosphorylation of eIF2α 
(eukaryotic translation initiation factor 2 α subunit) [7], 2) ac-
tivation of inositol-requiring 1 (IRE1)/X-box binding protein 
1 (XBP-1) and transcription factor (ATF6) through the in-
creased expression of ER chaperones and subsequent increase 
of ER folding capacity [8,9], 3) ER stress-associated protein deg-
radation, which degrades unfolded or improperly folded pro-
teins [10], and 4) apoptosis by the activation of CCAAT/en-
hancer-binding homologous protein (CHOP) [2,11].
  In addition, many intracellular signal transduction systems 
are generated by ER stress; recent studies indicate that the ex-
pression of tribbles-related protein 3 (TRB3) is increased by 
ER stress-activated ATF4 and CHOP [12]. TRB3 contributes 
to insulin resistance by physically interrupting phosphoryla-
tion of Akt/PKB, which is important for insulin transduction 
[13]. During fasting, activation of cAMP response element 
binding protein (CREB) in liver induces the expression of per-
oxisome proliferator-activated (PPAR)-gamma coactivator-1α 
(PGC-1α) and caused gluconeogenesis. In this situation, acti-
vated CREB/PGC-1α increases TRB3 expression and causes 
insulin resistance by interrupting insulin action, which in-
creases during food intake [14]. Additionally, TRB3 enters the 
nucleus by binding other transcription factors, which affects 
cellular growth, differentiation, and metabolism [13,15-17]. 
TRB3 in the nucleus is involved in the differentiation of adipo-
cytes by activating CCAAT/enhancer-binding protein β (C/
EBP) [18,19], and is also involved in lipid metabolism of adi-
pocytes by activating E3 ligase constitutive photomorphogen-
ic 1 (COP1) [20]. However, so far, there is little information on 
the role of TRB3 in pancreatic beta cells.
  The objectives of this study were to elucidate whether ER 
stress mediates the expression of TRB3 in INS-1 rat insulino-
ma cell line (INS-1 cell) and to determine the effect of TRB3 
on the expression of insulin gene using adenovirus containing 
TRB3. 
METHODS
Materials
Tunicamycin and thapsigargin used in the study were purchased 
from Sigma (St. Louis, MO, USA). The TRB3 antibodies used 
in the Western blot analysis were purchased from Calbiochem 
(La Jolla, CA, USA). Anti-rabbit antibodies and the radio-labeled 
probe ([α-
32P]dCTP) was purchased from Amersham Biosci-
ence (Little Chalfont, UK). Mouse TRB3 cDNA and recombi-
nant TRB3 adenovirus was provided by Professor Seong-Hoi 
Koo of the Sungkyunkwan University College of Medicine.
Cell incubation
Insulin dependent rat host-cells, INS-1 cells, with subculture 
numbers between 20 and 30, were maintained in RPMI 1640 
medium (Giboco-BRL, Grand Island, NY, USA) with 10% fetal 
bovine serum, 1 mM pyruvate, 10 mM HEPES, 50 mM 2-mer-
captoethanol, 100 units/mL penicillin, 100 μg/mL streptomy-
cin and incubated in 5% CO2/95% air at 37°C. The medium 
was changed every 3-4 days and was successively cultured us-
ing trypsin-EDTA.
Preparation of recombinant adenovirus
LacZ expressing adenovirus was used as a control for recom-
binant TRB3 adenovirus. The cDNA encoding a LacZ was in-
serted into the pAdTrack-CMV shuttle vector. The vector con-
struct was then electroporated into BJ5138 cells, and a recom-
binant vector was generated using the AdEasy adenoviral vector 
system. The recombinant viruses were amplified in HEK-293 
cells and purified by CsCl (Sigma) gradient centrifugation. Vi-
ral preparations were collected and desalted, and titers were de-
termined using Adeno-X rapid titer (BD Bioscience, San Jose, 
CA, USA), according to the manufacturer’s instructions. 
Northern blot analysis
INS-1 cells were treated with tunicamycin and thapsigargin, 
and infected with adenoviral vectors expressing TRB3. Cells 
were harvested at the indicated times, total RNA was isolated 
using Trizol reagent (Invitrogen, Carlsbad, CA, USA) accord-
ing to the manufacturer’s instructions, and 20 μg of total RNA 
from each sample was used. The probes for insulin, PDX-1 and 
MafA were labeled with [α-
32P]dCTP using a random-primer 
DNA-labeling system (Amersham Biosciences, Little Chalfont, 
UK).
Western blot analysis
INS-1 cells were treated with tunicamycin and thapsigargin 
for various times and then harvested in lysis buffer (50 mmol/
L Tris-HCl [pH 8.0], 150 mmol/L NaCl, 1 mmol/L EDTA, 1% 
Nonidet P-40, 0.25% Na-dexoycholate) containing proteinase 
inhibitors. The proteins were resolved by SDS-PAGE and then 
transferred electrophoretically to a polyvinyl difluoride mem-314
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brane (Millipore, Bedford, MA, USA). The membrane was 
blocked by incubation in blocking buffer, incubated with anti-
TRB3 antibody and was then developed using an ECL Western 
blot detection kit (Amersham Biosciences). The membrane was 
reblotted with anti-actin antibody to verify equal loading of 
protein in each lane. Densitometry was used to quantitate the 
results, using the digitalized scientific software program UN-
SCAN-IT (Skik Scientific Co., Orem, UT, USA). 
Luciferase activity measurement 
INS-1 cells were plated at a density of 3 × 10
5 cell per well in a 
12-well plate and subcultured for 2 days in INS-1 medium. The 
promoter constructs (300 ng/well) and other DNAs were tran-
siently transfected by using Lipofectamine
TM 2000 transfection 
reagent (Invitrogen). β-galactosidase plasmids were co-trans-
fected as an internal control. Cells were transfected for 4 hours, 
washed to remove plasmids. Cells were harvested approximate-
ly 24 hours after transfection for luciferase and β-galactosidase 
assays. 20 μL of cell lysate containing 15 μg of protein was ana-
lyzed by using the Luciferase assay system according to the 
manufacturer’s instructions (Promega, Madison, WI, USA). 
Luciferase activity was detected using a SIRUS Luminometer 
(Berthold, Pforzheim, Germany). The luciferase activity was 
normalized by using the β-galactosidase activity. 
Induction of ER stress
Tunicamycin and thapsigargin were used to induce ER stress 
in INS cells. Insulin expression was measured after 24 hours of 
treatment with 2 μg/mL tunicamycin, and after 5 hours of treat-
ment with 1 μM thapsigargin. Additionally, TRB3 protein ex-
pression was measured at an indicated time point after treat-
ment of tunicamycin and thapsigargin. 
Statistical analysis
The results are given as the average ± standard deviation, and 
Duncan’s test was used to analyze variables. Cases with a P val-
ue lower than 0.05 were statistically significant for determina-
tion, and all trials were independently run over three times. 
RESULTS
The effect of ER stress on insulin gene expression in INS-1 
cells
To determine the effect of ER stress on the insulin gene expres-
sion, INS-1 cells were treated with the ER stress-inducing sub-
stances, tunicamycin and thapsigargin, and the changes in in-
sulin mRNA were observed through Northern blot analysis. 
As shown in Fig. 1, control INS-1 cells showed high insulin 
mRNA expression, but INS-1 cells treated with tunicamycin 
and thapsigargin showed significantly decreased insulin mRNA 
expression.
Effect of ER stress on TRB3 expression in INS-1 cells
To determine the effects of ER stress on the expression of TRB3 
in INS-1 cells, cells were treated with tunicamycin and thap-
sargin and the changes in the TRB3 expression were measured 
after 1, 3, 6, and 12 hours using Western blot analysis. At base-
line, the expression of TRB3 in INS-1 cells was weak. When 
treated with tunicamycin, TRB3 expression started to increase 
at 3 hours, reached its maximum rate at 6 hours, and continued 
to increase up to 12 hours. When treated with thapsigargin, 
TRB3 expression was slightly increased at 3 hours and contin-
ued to increase up to 12 hours (Fig. 2).
Effects of TRB3 adenovirus on insulin gene expression 
To observe the effects of the ER-induced increase in TRB3 on 
the expression of the insulin gene in INS-1 cells, TRB3 overex-
Fig. 1.  The effects of tunicamycin and thapsigargin on insulin 
mRNA expression in INS-1 cells. Northern blot analysis of in-
sulin mRNA expression in INS-1 cells treated with tunicamy-
cin (A) and thapsigargin (B). INS-1 cells were treated with tu-
nicamycin (2 μg/mL) for 24 hours or thapsigargin (1 μM) for 
5 hours. 18S rRNA levels were analyzed as an internal control. 
Data in bar graph are the mean ± SEM of three independent 
measurements. 
aP < 0.01 and 
bP < 0.001 compared to control.
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pressing adenoviruses were prepared. After infecting INS-1 cells 
with TRB3-expressing adenovirus at varying concentrations, 
the proportional increase in TRB3 expression was confirmed 
(Fig. 3). Control INS-1 cells showed high expression of insulin 
mRNA. However, when TRB3 overexpression was induced with 
adenovirus, there was a dose-dependent decrease in insulin 
mRNA expression (Fig. 3). The decrease in insulin gene expres-
sion caused by TRB3 is not an effect of adenovirus because in-
sulin mRNA expression did not decrease in response to the 
control LacZ-expressing adenovirus (Fig. 3). 
The effects of TRB3 on insulin promoter activity 
In order to determine the effect of TRB3 on insulin gene tran-
scriptional activity, a human insulin promoter-expressing vector 
and TRB3 expressing vector were cotransfected in INS-1 cells. 
With this approach, we measured the activity of luciferase under 
the control of the insulin transcriptional promoter. As shown in 
Fig. 4, insulin promoter luciferase activity decreased in a dose-
dependent manner with the TRB3 expressing vector. Thus, TRB3 
appears to suppress gene expression that is regulated by the in-
sulin gene transcription promoter region.
The effects of TRB3 on the expression of MafA and PDX-1 
in INS-1 cells
Finally, we examined the effects of TRB3 on the expression of 
the pancreatic beta cell specific transcription factors, PDX-1 
and MafA, which stimulate the expression of insulin mRNA. 
At baseline, INS-1 cells expressed high levels of PDX-1 and 
MafA mRNA, but when infected with adenovirus TRB3, the 
cells demonstrated significantly decreased PDX-1 mRNA ex-
pression but had no effect on the expression of MafA mRNA 
(Fig. 3). 
DISCUSSION 
Several studies have demonstrated that in pancreatic beta cells 
with well developed ERs, beta cell dysfunction caused by ER 
stress can contribute to diabetes [21-25]. Initially, in obesity or 
Tunicamycin
TRB3
β-actin
Time (hr)  0  1  3  6  12
Thapsigargin
TRB3
β-actin
Time (hr)  0  1  3  6  12
Fig. 2.  The effects of tunicamycin and thapsigargin on TRB3 protein expression in INS-1 cells. Western blot analysis of TRB3 
protein expression in the presence of tunicamycin (A) and thapsigargin (B). INS-1 cells were incubated with tunicamycin (2 µg/
mL) and thapsigargin (1 µM) for indicated times. β-actin protein levels were analyzed as an internal control. The data in bar 
graph are the mean ± SEM of three independent measurements. 
aP < 0.01 and 
bP < 0.001 compared to 0 hour.
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type 2 diabetes, in order for the body to overcome insulin re-
sistance in peripheral tissues and maintain normal blood glu-
cose levels, hyperinsulinemia occurs. Thus, in long term con-
tinued cases of insulin resistance, demands for insulin synthe-
sis and secretion continuously increase preproinsulin protein 
influx into the ER of pancreatic beta cells to maintain homoeo-
static glucose metabolism and cause ER stress [2]. Therefore, 
the ER plays an important role in beta cell function. It can be 
assumed that beta cell dysfunction caused by ER stress can cause 
diabetes. Our previous study indicated that exposing INS-1 
cells to high glucose conditions for a long time can reduce in-
sulin gene expression due to glucose toxicity [26]. Additional-
ly, chronic hyperglycemia causes ER stress in INS-1 cells and 
the pancreas islets of OLETF rats [6]. Our previous study indi-
cated that the mechanism of ER stress-induced insulin gene 
suppression is related to the activation of ATF6 [6]. This study 
also showed that treating INS-1 cells with tunicamycin and 
thapsigargin results in a decrease in insulin gene expression, 
which agrees with results from our previous work. In addition, 
in this study, we confirmed that TRB3 reduces insulin gene 
expression in response to ER stress. 
  TRB3 is expressed during fasting in the liver through the ac-
tivation of the PPAR-α/PGC-1α pathway and causes insulin 
resistance by suppressing Akt/PKB activity [13,27]. Bi et al. [28] 
reported that TRB3 can cause insulin resistance in adipose tis-
sues. In metabolic syndrome-induced rats, it has been report-
ed that there is an increase in TRB3 and significant decrease in 
Akt phosphorylation in adipose tissue. Collectively, these data 
showed that TRB3 affects insulin resistance not only in liver tis-
sue, but also in adipose tissue. It has been reported that ER stress 
induces the expression of TRB3 in a variety of cells. Corcoran et 
al. [29] reported that ER stress induces expression of TRB3 in 
the MCF-7 human breast cancer cell line, DU 145 human 
prostate cancer cell, and H1299 human lung cancer cell, etc. 
Fig. 3.  The effects of adenovirus-mediated overexpression of 
TRB3 on insulin, PDX-1 and MafA mRNA expression. North-
ern blot analysis of insulin, PDX-1 and MafA mRNA expres-
sion in INS-1 cells infected with adenovirus encoding TRB3 
(Ad-TRB3). INS-1 cells were infected with the indicated doses 
of Ad-TRB3 or Ad-LacZ for 24 hours. 18S rRNA levels were 
analyzed as an internal control. Data in the bar graph are the 
mean ± SEM of three independent measurements. 
aP < 0.01 
and 
bP < 0.001 compared to control. 
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Additionally, it has been reported that tunicamycin increases 
the expression of TRB3 in human embryonic kidney cells and 
HepG2 liver cancer cells [12]. In this experiment, we confirmed 
that tunicamycin and thapsigargin induced ER stress and in-
creased the expression of TRB3 in INS-1 rat insulinoma cells. 
  Recently, Qian et al. [30] reported that the increased expres-
sion of TRB3 as a result of glucose toxicity and ER stress in-
duces apoptosis and dysfunction of the pancreatic beta cells. 
In this study, we investigated the effect of ER stress-induced 
TRB3 expression on insulin gene expression. When TRB3 was 
overexpressed in INS-1 cells by infecting the cells with TRB3 
expressing adenovirus, the expression of the insulin gene was 
significantly decreased. Additionally, it was confirmed that 
when human insulin gene transcription promoter and TRB3 
are cotransfected in INS-1 cells, insulin gene transcription 
promoter activation is significantly decreased. These results 
suggest that TRB3 suppresses the expression of the insulin gene 
in at the transcriptional level. However, in order to confirm 
that ER stress-induced TRB3 expression is directly related to 
insulin gene suppression, it is necessary to elucidate whether 
suppression of TRB3 expression prevents ER stress-induced 
suppression of insulin gene expression. 
  There are various transcription factors that regulate insulin 
gene expression at the insulin transcription promoter site. 
Among them, PDX-1 and MafA are important transcription 
factors that are involved in expression of insulin gene and are 
related to pancreatic beta cell function [31-36]. PDX-1 is an 
essential transcription factor for maintaining pancreatic devel-
opment and beta cell differentiation and function [37]. MafA 
controls insulin transcription and also plays an important role 
in beta cell function [35]. Thus, inhibition of PDX-1 and MafA 
expression is closely related to beta cell dysfunction and diabe-
tes [38]. In this experiment, we studied the effect that TRB3 on 
the expression of MafA and PDX-1. We confirmed that when 
TRB3 is overexpressed with adenovirus in INS-1 cells, MafA 
gene expression is not affected, while PDX-1 mRNA expression 
decreases. In order to verify whether the decrease in PDX-1 ex-
pression is directly related to the TRB3-dependent insulin gene 
suppression, additional studies are necessary to determine if 
the overexpression of PDX-1 offsets the effect of TRB3, which 
reduces insulin expression. 
  In summary, factors causing ER stress in the INS-1 cells in-
crease TRB3 expression. When TRB3 is overexpressed, insulin 
gene expression is suppressed. The TRB3-induced decrease in 
insulin gene expression is associated with the TRB3-induced 
suppression of PDX-1.
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